MKI67 and breast cancer: These results in combination with Ki-67 and cleaved PARP1 immunostaining experiments suggest that ISG12 overexpression impairs the estradiol signaling pathway that is responsible for both the E2-dependent proliferation and the TOT-induced apoptosis in breast cancer cells.